Jefferies Downgrades China Biologic Products (CBPO) to Underperform

March 11, 2019 4:42 AM EDT Send to a Friend
Jefferies analyst Johnny Kin Man Wong downgraded China Biologic Products (NASDAQ: CBPO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login